High levels of pathogens and other contaminants requires increased use of chlorine during purification. Unfortunately, chlorine produces carcinogenic by-products known as TTHMs. Because our Biotechnology Solutions reduce such contaminants, so reducing the amount of chlorine required in treatment, TTHMs are also reduced.
The graph shows data from two purification plants on a large reservoir where our solution was implemented (blue) and a purification plant on a reservoir where our solution has not yet been implemented (red).
Compliance has achieved for the two treatment plants on the reservoir where we have delivered our solution but the plant on the other reservoir remains cannot achieve compliance.